Badr, Gamal
Overview
Works: | 11 works in 14 publications in 2 languages and 26 library holdings |
---|---|
Roles: | Author, Other |
Classifications: | QH345, 616.079 |
Publication Timeline
.
Most widely held works about
Gamal Badr
- Gulf Canada Gallery presents: Main Gallery, Julie Ann Farkas, Gamal Badr, Pat Strakowski, October 26-November 10, 1988 by Gulf Canada Gallery (Calgary)( Book )
Most widely held works by
Gamal Badr
Régulation du chimiotactisme des lymphocytes B humains par les cytokines et la protéine gp120 du VIH-1 by
Gamal Badr(
Book
)
in French and held by 4 WorldCat member libraries worldwide
in French and held by 4 WorldCat member libraries worldwide
<> by
Gamal Badr(
)
2 editions published in 2013 in English and held by 4 WorldCat member libraries worldwide
2 editions published in 2013 in English and held by 4 WorldCat member libraries worldwide
<> by
Gamal Badr(
)
2 editions published in 2012 in English and held by 4 WorldCat member libraries worldwide
2 editions published in 2012 in English and held by 4 WorldCat member libraries worldwide
Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond by
Olivier Garraud(
)
1 edition published in 2012 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2012 in English and held by 2 WorldCat member libraries worldwide
Corruption of Human Follicular B-Lymphocyte Trafficking by a B-Cell Superantigen by
Gwenoline Borhis(
)
1 edition published in 2012 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2012 in English and held by 2 WorldCat member libraries worldwide
Effects of undenatured whey protein supplementation on CXCL12- and CCL21-mediated B and T cell chemotaxis in diabetic mice by
Gamal Badr(
)
1 edition published in 2011 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2011 in English and held by 2 WorldCat member libraries worldwide
Exposure to radioactive rocks from the Egyptian eastern desert attenuates the efficiency of the immune organs and induces
apoptosis of blood lymphocytes in rat model by
Gamal Badr(
)
1 edition published in 2020 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2020 in English and held by 2 WorldCat member libraries worldwide
Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by
modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling by
Gamal Badr(
)
1 edition published in 2013 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2013 in English and held by 2 WorldCat member libraries worldwide
Wound healing: time to look for intelligent, 'natural' immunological approaches? by
Olivier Garraud(
)
1 edition published in 2017 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2017 in English and held by 2 WorldCat member libraries worldwide
Ameliorative role of camel whey protein and rosuvastatin on induced dyslipidemia in mice(
)
1 edition published in 2018 in English and held by 1 WorldCat member library worldwide
Abstract : Activity of camel whey protein against dyslipidemia. Abstract : The incidence of obesity is rapidly increasing throughout the world. Dyslipidemia is a major risk factor for a number of chronic diseases, including diabetes and cardiovascular diseases. This work presents a novel approach to study the activity of camel whey protein (WP) with antioxidant and anti-inflammatory properties as a cheap dietary protein substance extracted from camel milk to produce satiety and help in building muscles. Mice model suffering from dyslipidemia as a result of feeding on high fat-cholesterol diet for 8 weeks were administrated with either camel WP and/or rosuvastatin for 4 weeks. Dyslipidemia revealed significant increase in anthropometrical measurements, levels of glucose, insulin, cholesterol, triglycerides, low-density lipoprotein, total leucocyte count, inflammatory cytokines and reactive oxygen species, accompanied by a significant elevation in activating transcription factor-3 and inducible nitric oxide synthase expressions. These alterations were correlated with a profound reduction in high-density lipoprotein, peroxisome proliferator-activated receptor alpha and adiponectin along with a decrease in liver and muscle mitochondrial proteins. Rosuvastatin treatment to mice suffering from dyslipidemia in combination with camel WP for 4 weeks ameliorated these parameters. Notably, animals treated with both camel WP and rosuvastatin exhibited a remarkable decrease in the incidence of dyslipidemia. In addition, camel WP succeeded to overcome the therapeutic drawback posed from rosuvastatin therapy alone with minimal side effects
1 edition published in 2018 in English and held by 1 WorldCat member library worldwide
Abstract : Activity of camel whey protein against dyslipidemia. Abstract : The incidence of obesity is rapidly increasing throughout the world. Dyslipidemia is a major risk factor for a number of chronic diseases, including diabetes and cardiovascular diseases. This work presents a novel approach to study the activity of camel whey protein (WP) with antioxidant and anti-inflammatory properties as a cheap dietary protein substance extracted from camel milk to produce satiety and help in building muscles. Mice model suffering from dyslipidemia as a result of feeding on high fat-cholesterol diet for 8 weeks were administrated with either camel WP and/or rosuvastatin for 4 weeks. Dyslipidemia revealed significant increase in anthropometrical measurements, levels of glucose, insulin, cholesterol, triglycerides, low-density lipoprotein, total leucocyte count, inflammatory cytokines and reactive oxygen species, accompanied by a significant elevation in activating transcription factor-3 and inducible nitric oxide synthase expressions. These alterations were correlated with a profound reduction in high-density lipoprotein, peroxisome proliferator-activated receptor alpha and adiponectin along with a decrease in liver and muscle mitochondrial proteins. Rosuvastatin treatment to mice suffering from dyslipidemia in combination with camel WP for 4 weeks ameliorated these parameters. Notably, animals treated with both camel WP and rosuvastatin exhibited a remarkable decrease in the incidence of dyslipidemia. In addition, camel WP succeeded to overcome the therapeutic drawback posed from rosuvastatin therapy alone with minimal side effects
Audience Level
0 |
![]() |
1 | ||
General | Special |

- SpringerLink (Online service) Other
- Richard, Yolande Other Thesis advisor
- Al-Sadoon, Mohamed K. Contributor
- Daghestani, Maha Contributor
- Université Paris-Sud (1970-2019) Degree grantor
- Garraud, Olivier Author
- El-Toni, Ahmed M. Contributor
- Borhis, Gwenoline Author
- Université de Paris-Sud Faculté de médecine (Le Kremlin-Bicêtre, Val-de-Marne) Degree grantor
- El-Reda, Ghada Abd